TORONTO DOMINION BANK

Bank

Position in PTCT — Ptc Therapeutics, Inc.

CIK 947263 TORONTO, ONTARIO, A6

Position in PTCT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$176,668,057

-$29,490,801 QoQ

Shares Held

2,165,846

-28.4% QoQ

Ownership

2.60%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

of 380 holders

Holding Since

Dec 2021

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TORONTO DOMINION BANK holds $769,395,513 across 60 Biotechnology names. PTCT ranks #1 (23.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PTCT	Ptc Therapeutics, Inc. This page	2,165,846	$176,668,057
2	CELC	Celcuity Inc.	1,258,758	$131,691,261
3	STOK	Stoke Therapeutics, Inc.	3,173,258	$103,829,001
4	MDGL	Madrigal Pharmaceuticals, Inc.	181,432	$97,419,912
5	VRTX	Vertex Pharmaceuticals Inc / Ma	85,391	$42,416,270
6	TARS	Tarsus Pharmaceuticals, Inc.	510,253	$32,115,323
7	REGN	Regeneron Pharmaceuticals, Inc.	48,783	$30,418,151
8	NGNE	Neurogene Inc.	681,337	$21,428,048

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$176,668,057	2,165,846	-28.4%	Shares	Defined	2026-08-14
2026-03-31	$206,158,858	3,025,963	-26.9%	Shares	Defined	2026-05-15
2025-12-31	$314,338,811	4,138,215	+27.5%	Shares	Sole	2026-02-17
2025-12-31	$314,338,811	4,138,215	—	Shares	Sole	2026-02-13
2025-09-30	$199,239,239	3,246,525	+32.7%	Shares	Defined	2025-11-14
2025-06-30	$119,460,588	2,445,958	-6.4%	Shares	Defined	2025-08-14
2025-03-31	$133,168,468	2,613,196	-20.5%	Shares	Defined	2025-05-15
2024-12-31	$148,362,947	3,286,729	+4282.2%	Shares	Defined	2025-02-19
2021-12-31	$2,987,289	75,001	—	Shares	Sole	2022-02-04
No filing history on record for this holder in this stock.